Sherry Aulin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sherry Aulin
Earlier roles on record: CFO at Xenon Pharmaceuticals Inc. (XENE) until June 30, 2025. Xenon Pharmaceuticals Inc. reported in an 8-K filed July 3, 2025 that Sherry Aulin resigned as Chief Financial Officer, effective June 30, 2025. Xenon Pharmaceuticals Inc. reported in an 8-K filed February 27, 2025 that Sherry Aulin resigned as Chief Financial Officer, effective June 30, 2025. The proxy statement of Xenon Pharmaceuticals Inc. reports total compensation of $356,453 for Sherry Aulin in fiscal 2025, including a base salary of $330,441. Disclosed compensation is on record for 5 fiscal years. Sherry Aulin has spoken on 18 earnings calls across 1 company, most recently for Xenon Pharmaceuticals Inc. on May 12, 2025.
“effective upon the resignation of Sherry Aulin as the Company's Chief Financial Officer on June 30, 2025.”
“On February 24, 2025, Ms. Sherry Aulin notified the Company of her decision to resign as Chief Financial Officer, effective June 30, 2025, for personal reasons.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-06-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xenon Pharmaceuticals Inc. (XENE) | Former Chief Financial Officer | $330,441 | $356,453 |
| 2024 | Xenon Pharmaceuticals Inc. (XENE) | Former Chief Financial Officer | $509,717 | $4,164,888 |
| 2023 | Xenon Pharmaceuticals Inc. (XENE) | Chief Financial Officer | $465,678 | $3,523,045 |
| 2022 | Xenon Pharmaceuticals Inc. (XENE) | Chief Financial Officer | $425,284 | $3,212,859 |
| 2021 | Xenon Pharmaceuticals Inc. (XENE) | Chief Financial Officer | $282,729 | $2,008,525 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.